Neovasc_Logo-web-header.jpg
Shockwave Medical Completes Acquisition of Neovasc
11. April 2023 08:20 ET | Neovasc, Inc.
SANTA CLARA, CA, April 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Shockwave Medical, Inc. (NASDAQ: SWAV) (“Shockwave”), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat...
Neovasc_Logo-web-header.jpg
Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update
31. März 2023 16:11 ET | Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fourth...
Neovasc_Logo-web-header.jpg
Neovasc Shareholders Approve Acquisition by Shockwave Medical
06. März 2023 17:37 ET | Neovasc, Inc.
VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices...
Neovasc_Logo-web-header.jpg
Neovasc Announces German Reimbursement Renewal
01. Februar 2023 09:05 ET | Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Feb. 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. (“Neovasc” or “the Company”) (NASDAQ , TSX : NVCN) today announced the German Institute for the Hospital...
Neovasc_Logo-web-header.jpg
Shockwave Medical to Acquire Neovasc
17. Januar 2023 08:00 ET | Neovasc, Inc.
VANCOUVER, BC, Jan. 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ,TSX: NVCN), a leader in the development of minimally invasive devices for the...
Neovasc_Logo-web-header.jpg
Neovasc Announces Progress on COSIRA-II Clinical Trial
28. November 2022 16:45 ET | Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Nov. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced an update on the COSIRA-II Clinical...
Neovasc_Logo-web-header.jpg
Neovasc Comments on European Heart Journal Publication
18. November 2022 09:05 ET | Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Nov. 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that European Heart Journal - Case...
Neovasc_Logo-web-header.jpg
Neovasc Announces Third Quarter Financial Results and Provides Corporate Update
10. November 2022 16:05 ET | Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Nov. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the third quarter...
Neovasc_Logo-web-header.jpg
Neovasc Reducer Obtains U.S. Outpatient Reimbursement
08. November 2022 09:05 ET | Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Nov. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the Centers for Medicare and...
Neovasc_Logo-web-header.jpg
Neovasc to Report Third Quarter Financial Results on November 10, 2022
27. Oktober 2022 09:00 ET | Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Oct. 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (NASDAQ ,  TSX : NVCN) will report financial results for the quarter ended September 30, 2022 on...